Case Study: SMB Pharma Company achieves successful orphan drug commercialization with Axtria DataMAx™

A Axtria Case Study

Preview of the an SMB pharma organization Case Study

SMB Pharma Company prepares for orphan drug launch with Axtria and taps a $217B market

The SMB Pharma Company, a small-to-medium-sized business in the pharmaceutical industry, faced the challenge of commercializing an orphan drug, a process that differs significantly from non-rare disease treatments. To tap into this growing market, the company needed a robust commercial data platform to ensure a successful product launch and turned to vendor Axtria for a solution using its Axtria DataMAx™ product.

Axtria implemented its data-to-insights-to-operations expertise to develop a commercial data platform for the SMB pharma client. The solution enabled robust commercial planning, daily patient onboarding tracking, and proactive identification of risks that could cause patient drop-out. This resulted in all critical system capabilities being ready well before the commercial launch, ensuring a HIPAA-compliant foundation for driving the drug's commercial success.


View this case study…

Axtria

96 Case Studies